Related Experiment Video
Updated: Mar 25, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter
Theodor Baars1, Ursula Neumann, Mona Jinawy
1From the Department for Cardiology, West German Heart and Vascular Centre Essen, University Hospital, University Duisburg-Essen, Essen, Germany (TB, MJ, SH, RE); Department of Bioinformatics, Straubing Center of Science, University of Applied Science Weihenstephan-Triesdorf, Straubing, Germany (UN, MR, DH); and Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen (J-PS, JK, GG, AC), Essen, Germany.
Insights
Noninvasive liver enzymes and routine blood markers can predict coronary artery stenosis severity in acute myocardial infarction (AMI) patients. This may reduce the need for invasive cardiac catheterization in low-risk individuals.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Background:
- Acute myocardial infarction (AMI) necessitates accurate risk stratification to guide treatment.
- Intracardiac catheterization, while definitive, carries risks and complications.
- Liver enzymes are implicated in cardiovascular disease risk, suggesting a potential role in AMI assessment.
Purpose of the Study:
- To analyze the predictive value of liver serum markers for coronary artery stenosis severity in AMI patients.
- To identify noninvasive parameters that can assess stenosis severity, potentially avoiding invasive procedures.
Main Methods:
- Retrospective evaluation of 437 AMI patients undergoing percutaneous coronary intervention (PCI).
- Quantitative coronary angiography to determine minimal lumen diameter (MLD) and percent stenosis diameter (SD).
- Random forests (RF) analysis to associate routine heart and liver parameters with SD, developing a prediction model (M10).
Main Results:
- Significant differences in age, alkaline phosphatase (AP), aspartate aminotransferase (AST), and MLD were observed between stenosis severity groups (SD ≥ 50% vs. < 50%).
- Age, AST, alanine aminotransferase (ALT), and troponin correlated significantly with SD; MLD showed an inverse correlation.
- The M10 model (including age, BMI, AP, AST, ALT, gamma-glutamyltransferase, creatinine, troponin) achieved an AUC of 69.7% for predicting stenosis severity.
Conclusions:
- Routine liver parameters are significantly associated with coronary artery stenosis severity in AMI.
- A noninvasive model using readily available parameters can identify stenosis severity in AMI.
- This approach may help avoid unnecessary coronary angiography in lower-risk AMI patients.
Abstract:
Detection of high-risk subjects in acute myocardial infarction (AMI) by noninvasive means would reduce the need for intracardiac catheterization and associated complications. Liver enzymes are associated with cardiovascular disease risk. A potential predictive value for liver serum markers for the severity of stenosis in AMI was analyzed.Patients with AMI undergoing percutaneous coronary intervention (PCI; n = 437) were retrospectively evaluated. Minimal lumen diameter (MLD) and percent stenosis diameter (SD) were determined from quantitative coronary angiography. Patients were classified according to the severity of stenosis (SD ≥ 50%, n = 357; SD < 50%, n = 80). Routine heart and liver parameters were associated with SD using random forests (RF). A prediction model (M10) was developed based on parameter importance analysis in RF.Age, alkaline phosphatase (AP), aspartate aminotransferase (AST), and MLD differed significantly between SD ≥ 50 and SD < 50. Age, AST, alanine aminotransferase (ALT), and troponin correlated significantly with SD, whereas MLD correlated inversely with SD. M10 (age, BMI, AP, AST, ALT, gamma-glutamyltransferase, creatinine, troponin) reached an AUC of 69.7% (CI 63.8-75.5%, P < 0.0001).Routine liver parameters are associated with SD in AMI. A small set of noninvasively determined parameters can identify SD in AMI, and might avoid unnecessary coronary angiography in patients with low risk. The model can be accessed via http://stenosis.heiderlab.de.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations

